April 2016 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Feature Articles
- Sanofi EVP Weighs In On The Politics Of Drug Pricing
- Hot New Therapeutic MOAs Versus Neurodegenerative Diseases
The Enterprisers
Capitol Perspectives
Companies To Watch
Inside The Industry
- Takeda CEO Mandate Sets Off A Nano Reaction
- Is Kyle Bass’ IPR Crusade Reshaping Pharma Business?
- GW Pharmaceuticals Changes Its Focus To Rare Diseases
Leadership Lessons
Ask The Board
This website uses cookies to ensure you get the best experience on our website. Learn more